Jade Williams, Author at European Medical Journal - Page 6 of 22

Illustration of a heart with a monitor

Heart failure drug market to reach $33.7bn by 2032

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe and Japan.

Ahmad Awada

Onc Now: Episode 8: New Frontiers in Oncology and Drug Development

Ahmad Awada, Head of the Oncology Department at Chirec Cancer Institute discusses groundbreaking developments in cancer care.

Handshake on blue background

Vertex strikes deal for Orna Therapeutics' LNP technology

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and beta-thalassemia.

Gold crown on blue background

Could Eli Lilly take the crown in the obesity market?

According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.

Researchers

Gene therapy from Novartis shows promise for children with SMA

Novartis’ Phase III study has demonstrated significant improvement in motor function in children and young adults with spinal muscular atrophy

contract

Dr Dietmar Berger appointed as Gilead’s next Chief Medical Officer

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.

Researchers

UK improves global clinical trial ranking, but hurdles remain

The UK is regaining its position as a global hub for industry clinical trials, according to the ABPI, but challenges remain in the space.

Dr Cecilia Caetano, Bayer

Bayer’s Dr Cecilia Caetano on making space for menopause

Find out how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Women’s Health, Bayer.

Coin stacks

Amgen expands biomanufacturing footprint in North Carolina

Amgen is investing $1bn to build a second drug substance manufacturing facility in Holly Springs, North Carolina – increasing the company’s total planned investment in the region to more than $1.5bn.

Ed Smith

Onc Now: Episode 6: Revolutionising Paediatric Radiation Oncology – Part 1

Join Ed Smith, Professor at the University of Manchester, UK, to discuss the revolutionary potential of proton beam therapy and radiation oncology.